AREDS was a randomized, placebo-controlled study involving thousands of participants aged 55-80 years, who were followed for an average of 6.3 years. Participants were categorized into different groups based on their AMD status and were given either the study supplements or a placebo. Regular eye exams and questionnaires were used to track the progression of AMD and the development of cataracts.
